- Home
- IDT vs MNKD Comparison
IDT vs MNKD Comparison
Compare IDT & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDT
- MNKD
- Stock Information
- Founded
- IDT 1990
- MNKD 1991
- Country
- IDT United States
- MNKD United States
- Employees
- IDT N/A
- MNKD N/A
- Industry
- IDT Telecommunications Equipment
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- IDT Telecommunications
- MNKD Health Care
- Exchange
- IDT Nasdaq
- MNKD Nasdaq
- Market Cap
- IDT 1.2B
- MNKD 1.4B
- IPO Year
- IDT 1996
- MNKD 2004
- Fundamental
- Price
- IDT $57.58
- MNKD $4.57
- Analyst Decision
- IDT
- MNKD Buy
- Analyst Count
- IDT 0
- MNKD 6
- Target Price
- IDT N/A
- MNKD $8.92
- AVG Volume (30 Days)
- IDT 116.7K
- MNKD 1.7M
- Earning Date
- IDT 06-04-2025
- MNKD 05-08-2025
- Dividend Yield
- IDT 0.42%
- MNKD N/A
- EPS Growth
- IDT 117.30
- MNKD 228.27
- EPS
- IDT 3.15
- MNKD 0.10
- Revenue
- IDT $1,221,391,000.00
- MNKD $297,595,000.00
- Revenue This Year
- IDT N/A
- MNKD $14.23
- Revenue Next Year
- IDT N/A
- MNKD $14.56
- P/E Ratio
- IDT $18.35
- MNKD $44.11
- Revenue Growth
- IDT 1.75
- MNKD 32.50
- 52 Week Low
- IDT $33.84
- MNKD $4.17
- 52 Week High
- IDT $58.77
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- IDT 76.50
- MNKD 41.68
- Support Level
- IDT $51.61
- MNKD $4.52
- Resistance Level
- IDT $58.56
- MNKD $4.83
- Average True Range (ATR)
- IDT 1.33
- MNKD 0.20
- MACD
- IDT 0.80
- MNKD -0.01
- Stochastic Oscillator
- IDT 90.42
- MNKD 22.06
About IDT IDT Corporation Class B
IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.